Skip to main content

Latest Articles

Latest Articles

Showing 9 / 742 Metabolic Health articles

GLP-1s Show Promise in MS, But More Rigorous Research Needed
Multiple Sclerosis

GLP-1s Show Promise in MS, But More Rigorous Research Needed

GLP-1 receptor agonists, originally developed for diabetes, are gaining attention for potential benefits in multiple sclerosis (MS) due to their effects on the brain and metabolic health. Expert Afsaneh Shirani, MD, highlighted promising studies at ACTRIMS, including weight loss and minimal relapses, but stressed the need for more rigorous trials. Key challenges like biomarkers, patient selection, and access remain.

Shotlee··6 min read